Monthly Archives: September 2019
L Brands’ Ties to Jeffrey Epstein Aren’t its Only Troubles as Stock Loses a Third of its Value
(CNBC) It’s been quite the year for L Brands. Sales continued to decline at its prized Victoria’s Secret stores. It faced an activist campaign that led to a board shakeup. Then came unwanted attention for its ties to accused child […]
One of the Oldest Quants Is Going All-In With Robots
(Bloomberg) A $7.5 billion money manager with roots almost as old as quant-investing itself is going all-in with machine learning. Millburn Ridgefield Corporation placed robots at the very heart of its open systematic strategies after a six-year experiment. Now, the […]
CFTC Charges Unregistered Forex Trading Firm and Its Principal with Fraud and Misappropriation
(HedgeCo.Net) The U.S. Commodity Futures Trading Commission has filed a civil enforcement action in the Southern District of New York against defendants Dominick Vincent Carducci and his company VOS Capital Management, LLC (VOS Capital), both of South Carolina. The defendants […]
Hedge Funds Getting Burned as Growth Stocks Trounced by Value
(Bloomberg) A hedge-fund favorite is rapidly losing ground in the stock market just as one of the industry’s least-loved sectors picks up. Growth stocks, generally companies that are seeing rapid profit increases, have dropped in seven of the past eight […]
Trump Says ‘Great News’ That Singer Hedge Fund Has Taken AT&T Stake
(Bloomberg) President Donald Trump said it’s “great news” that a hedge fund run by billionaire Paul Singer had taken a new position in AT&T Inc., saying he hoped the investment by Elliott Management Corp. would “put a stop to all […]
Fannie, Freddie Soar as Hedge Funds Score Wins on Two Fronts
(Bloomberg) Fannie Mae and Freddie Mac soared the most in almost three years Monday as hedge funds that have long hoped to make a windfall on their investments in the mortgage giants got a double-dose of good news. To read […]
London VC 4Bio Capital raises the first tranche of $150m ‘advanced therapies’ fund
(Opalesque) London-based biotech venture capital firm 4Bio Capital has raised the first $50m for a new $150m fund to invest in “advanced therapies” such as gene and cell therapy. Dmitry Kuzmin, the managing partner, said its 4Bio Ventures II fund […]
Thinking Ahead Institute reveals top fifteen extreme risks for investors
(Opalesque) The Thinking Ahead Institute’s (TAI) Extreme risks 2019 report and ranking, which categorises rare events that could have a high impact on global economic growth and asset returns, has a new top three: global temperature change, global trade collapse […]
Even Behind Bars, Martin Shkreli Is Still Filing Lawsuits
(Bloomberg) Convicted “Pharma Bro” Martin Shkreli is in prison serving a seven-year sentence, but that hasn’t tamed his appetite for using the courts to battle former colleagues and clients. On Friday, he claimed a former investor in his Elea Capital […]
Sentieo’s AI-Focused Research Platform Supercharges Equity Analysts’ Stock Picking Capabilities
(HedgeWeek) In a world awash with data, hedge fund equity analysts looking for that one data point that could generate alpha face a significant challenge, akin to finding a needle in a haystack. But as data volumes have grown, so […]
Bill Ackman’s $500 Million Bet on Himself Pays Off After Losing Streak
(Bloomberg) Bill Ackman made a big bet on himself even as some investors were second-guessing the future of his hedge fund, Pershing Square Capital Management. So far, it’s paying off. To read this article:
Ray Dalio Sees 25% Chance of Recession This Year and in 2020
(Bloomberg) Ray Dalio, the billionaire founder of the world’s largest hedge fund, said there’s about a 25% chance of a U.S. recession this year and in 2020 and that central bankers will be limited in addressing it. The Federal Reserve, […]